Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C4 | P17516 | 1/20 | 0.35 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.35 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.35 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26216515 | 0.89 | KDM4E (0.33) | AKR1C4AKR1C3AKR1C2AKR1C1KDM4E | |
| SCHEMBL25086334 | 0.82 | KDM4E (0.35) | AKR1C4AKR1C3AKR1C2AKR1C1KDM4E | |
| SCHEMBL26380790 | 0.81 | NR4A2 (0.33) | AKR1C4AKR1C3AKR1C2AKR1C1KDM4E | |
| SCHEMBL26215669 | 0.80 | KDM4E (0.36) | KDM4EATML3MBTL1 | |
| SCHEMBL18541214 | 0.80 | TSPO (0.36) | AKR1C4AKR1C3AKR1C2AKR1C1KDM4E | |
| SCHEMBL23768622 | 0.80 | AKR1C4 (0.34) | AKR1C4AKR1C3AKR1C2AKR1C1KDM4E | |
| SCHEMBL18126072 | 0.80 | L3MBTL1 (0.50) | KDM4EATML3MBTL1 | |
| SCHEMBL23768632 | 0.78 | AKR1C4 (0.34) | AKR1C4AKR1C3AKR1C2AKR1C1KDM4E | |
| SCHEMBL23008151 | 0.77 | L3MBTL1 (0.47) | KDM4EATML3MBTL1 | |
| SCHEMBL18126070 | 0.77 | L3MBTL1 (0.50) | KDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230292608-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2023-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230292608-A1 | Organic Electroluminescent Materials and Devices | ICMT, INMT, PNMT | AKR1C4 4057/4885AKR1C3 4179/4885AKR1C2 3891/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.